Annual report pursuant to section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.3.0.11
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended 55 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
Costs and expenses:      
Research and development $ 1,158,167 $ 584,298 $ 1,951,954
General and administrative 2,220,361 1,344,390 4,255,247
Operating Expenses, Total 3,378,528 1,928,688 6,207,201
Operating loss (3,378,528) (1,928,688) (6,207,201)
Gain on extinguishment of debt 0 0 7,908
Interest expense, net (91,585) (35,782) (195,387)
Net loss $ (3,470,113) $ (1,964,470) $ (6,394,680)
Net loss per common share, basic and diluted (in dollars per share) $ (0.16) $ (0.18)  
Weighted average common shares outstanding, basic and diluted (in shares) 21,425,632 11,175,096